2014
DOI: 10.1590/0037-8682-0240-2013
|View full text |Cite
|
Sign up to set email alerts
|

Prevalence and factors associated with lipodystrophy in AIDS patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
13
2

Year Published

2016
2016
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(15 citation statements)
references
References 42 publications
0
13
2
Order By: Relevance
“…Regarding the type of lipodystrophy, we observed that lipoatrophy was present in 37.8% of the patients, mainly in men (75%), followed by mixed lipodystrophy in 31.8% of the patients, 65.9% were men and the least frequent was lipohypertrophy, present in 30.4% of the patients, most of whom were male (65.9%). Our results are different from those reported by Justina et al (2014), who found greater prevalence of lipoatrophy (62.5%), and a lower frequency of lipohypertrophy (8.3%) and mixed lipodystrophy (29.2%). The variation in the frequency of lipodystrophy may also be due to a lack of standards to determine it, and the use of autoperception by the subject; also the diagnosis by the researcher could be subjective, even though it has been described in a publication (Loonam and Mullen, 2012).…”
Section: Discussioncontrasting
confidence: 99%
See 1 more Smart Citation
“…Regarding the type of lipodystrophy, we observed that lipoatrophy was present in 37.8% of the patients, mainly in men (75%), followed by mixed lipodystrophy in 31.8% of the patients, 65.9% were men and the least frequent was lipohypertrophy, present in 30.4% of the patients, most of whom were male (65.9%). Our results are different from those reported by Justina et al (2014), who found greater prevalence of lipoatrophy (62.5%), and a lower frequency of lipohypertrophy (8.3%) and mixed lipodystrophy (29.2%). The variation in the frequency of lipodystrophy may also be due to a lack of standards to determine it, and the use of autoperception by the subject; also the diagnosis by the researcher could be subjective, even though it has been described in a publication (Loonam and Mullen, 2012).…”
Section: Discussioncontrasting
confidence: 99%
“…However, Highly Active Antiretroviral Therapy (HAART) has turned a fatal into a chronic disease; but it has numerous side effects, including lipodystrophy syndrome (Montessori et al, 2004;Merck Manual, 2018), which is characterized by abnormal fat deposition and metabolic changes (Paton et al, 2002). Changes in fat deposition may result in lipoatrophy, reduction in facial, gluteal and member fat; lipohipertrophy and fat accumulation in the abdomen, neck and thorax, and mixed lipodystrophy, which is a combination of both (Justina et al, 2014). Metabolic changes can include an increase in triglycerides, total cholesterol, LDL-cholesterol, hyperglycemia and reduction in HDLcholesterol (Simha, 2014).…”
Section: Introductionmentioning
confidence: 99%
“…This disease is most likely a result of the interaction between antiretroviral therapy, virus infection, genetic factors, and the lifestyle of the individual. 32 …”
Section: Discussionmentioning
confidence: 99%
“…Out of 84 potentially eligible studies, 45 were included in this review [37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80]. The search strategy and reasons for exclusion are shown in Figure 1.…”
Section: Study Selectionmentioning
confidence: 99%